Microbot Medical (MBOT) Equity Ratio (2010 - 2026)

Microbot Medical has reported Equity Ratio for 17 years, with the latest figure at 0.95 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 1.29% year-over-year to 0.95; the trailing twelve-month figure through Mar 2026 stood at 0.95 (up 1.29% YoY), and the FY2025 full-year result was 0.95, up 62.49% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.95, roughly flat from 0.95 in the prior quarter.
• The five-year high for Equity Ratio was 0.96 in Q3 2025, with the low at 0.54 in Q4 2023.
• Historically, Equity Ratio has averaged 0.82 across 5 years, with a median of 0.83 in 2023.
• Annual changes were most pronounced in 2023 — Equity Ratio dropped 29.28% — and 2025, when it surged 62.49%.
• Microbot Medical's Equity Ratio stood at 0.76 in 2022, then retreated by 29.28% to 0.54 in 2023, then increased by 8.28% to 0.59 in 2024, then soared by 62.49% to 0.95 in 2025, then retreated by 0.19% to 0.95 in 2026.
• The last three Equity Ratio figures came in at 0.95 (Q1 2026), 0.95 (Q4 2025), and 0.96 (Q3 2025), per Business Quant data.